Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remifentanil added to propofol for abdominal surgery anesthesia
IRCT20250601066017N1Phase 3Completed
- Sponsor
- Islamic Azad University
- Start
- Sep 2025
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of remifentanil and propofol (2 arms), sponsored by Islamic Azad University. Primary endpoints: Hemodynamic changes and Postoperative pain. Started Sep 2025; status: completed.
02
Drugs
remifentanilpropofol
Beyond the preview
Go deeper on IRCT20250601066017N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20250601066017N1.